What if there is no reliable and appropriate medication for pregnancy hypertension available in Indonesian primary care?

Highlights

• The Indonesian medicine formulary has recently been revised and will be implemented in April 2020.

• Nifedipine will no longer be available in public primary care service (Puskesmas) according to the new formulary.

• This change will severely impact on the management of pregnancy hypertension in Indonesian primary care, given that very limited treatment options are currently available.

• Mortality caused by pregnancy hypertension in Indonesia continous to be unacceptably high.

• The decision to remove nifedipine from use in Indonesian public primary health must be urgently revisited.